Register to chat with like-minded investors on our interactive forums.
Period:
Draw Mode:
| Volume | 1,251,742 |
|
|||||
| News | - | ||||||
| Day High | 8.885 | Low High |
|||||
| Day Low | 8.70 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Aurinia Pharmaceuticals Inc | AUPH | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.09 | 1.03% | 8.86 | 19:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 8.85 | 8.70 | 8.885 | 8.86 | 8.77 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 11,466 | 1,251,742 | US$ 8.79 | US$ 11,008,732 | - | 4.07 - 12.43 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 18:59:59 | formt | 200 | US$ 8.86 | USD |
Aurinia Pharmaceuticals (AUPH) Options Flow Summary
Aurinia Pharmaceuticals Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 1.27B | 143.61M | - | 135.55M | -108.18M | -0.75 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Aurinia Pharmaceuticals News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical AUPH Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 8.59 | 9.125 | 8.42 | 8.88 | 1,787,465 | 0.27 | 3.14% |
| 1 Month | 7.60 | 10.05 | 7.50 | 8.72 | 2,176,109 | 1.26 | 16.58% |
| 3 Months | 9.08 | 10.05 | 6.9401 | 8.10 | 1,965,620 | -0.22 | -2.42% |
| 6 Months | 10.51 | 12.43 | 6.9401 | 9.23 | 2,029,102 | -1.65 | -15.7% |
| 1 Year | 4.65 | 12.43 | 4.07 | 9.09 | 2,512,537 | 4.21 | 90.54% |
| 3 Years | 15.13 | 33.9715 | 4.07 | 13.32 | 3,159,791 | -6.27 | -41.44% |
| 5 Years | 6.15 | 33.9715 | 3.52 | 13.23 | 2,422,911 | 2.71 | 44.07% |
Aurinia Pharmaceuticals Description
| Aurinia Pharmaceuticals Inc is a biopharmaceutical company. It provides products for patients suffering from serious diseases with a high unmet medical need. The firm is developing voclosporin, an investigational drug, for the treatment of lupus nephritis (LN), focal segmental glomerulosclerosis (FSGS), and Dry Eye Syndrome (DES). Geographically, it derives maximum revenue from the United States. |
